Non-clinical safety of monoclonal antibodies for human use

被引：0

作者：

Suzuki-Nishimura, Tamiko ^{[1
]}

机构：

[1] Pharmaceut & Med Devices Agcy, Tokyo 1000013, Japan

来源：

JOURNAL OF PHARMACOLOGICAL SCIENCES | 2008年 / 106卷

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：148P / 148P

页数：1

共 50 条

[1] Non-clinical safety of recently approved monoclonal antibodies for human use
Suzuki-Nishimura, Tamiko
JOURNAL OF PHARMACOLOGICAL SCIENCES, 2007, 103 : 161P - 161P
[2] Non-clinical safety and human subject protection during clinical trials of monoclonal antibodies and their analogs for human use
Suzuki-Nishimura, T
JOURNAL OF PHARMACOLOGICAL SCIENCES, 2006, 100 : 285P - 285P
[3] Non-clinical studies of recently approved monoclonal antibodies for human use and ICH guidelines
Suzuki-Nishimura, Tamiko
Kato, Yuuki
Kawakami, Ayaka
Hori, Toshiki
JOURNAL OF PHARMACOLOGICAL SCIENCES, 2011, 115 : 275P - 275P
[4] Designing non-clinical safety evaluation programmes for monoclonal antibodies for therapeutic use: A personal view
Bugelski, PJ
SAFETY EVALUATION OF BIOTECHNOLOGICALLY-DERIVED PHARMACEUTICALS: FACILITATING A SCIENTIFIC APPROACH, 1998, : 103 - 114
[5] Designing non-clinical safety evaluation programmes for monoclonal antibodies: Recommendations and the way forward
Green, J
Purves, J
SAFETY EVALUATION OF BIOTECHNOLOGICALLY-DERIVED PHARMACEUTICALS: FACILITATING A SCIENTIFIC APPROACH, 1998, : 151 - 157
[6] Non-clinical safety studies on biosimilar recombinant human erythropoietin
Parnham, Michael J.
Schindler-Horvat, Janice
Kozlovic, Marija
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2007, 100 (02) : 73 - 83
[7] Safety of recently approved monoclonal and polyclonal antibodies for human use
Suzuki-Nishimura, Tamiko
JOURNAL OF PHARMACOLOGICAL SCIENCES, 2010, 112 : 216P - 216P
[8] Non-clinical vaccine safety assessment
Verdier, F
TOXICOLOGY, 2002, 174 (01) : 37 - 43
[9] Preclinical and clinical safety of monoclonal antibodies
Tabrizi, Mohammad A.
Roskos, Lohn K.
DRUG DISCOVERY TODAY, 2007, 12 (13-14) : 540 - 547
[10] Oligonucleotide-based pharmaceuticals: Non-clinical and clinical safety signals and non-clinical testing strategies
Mustonen, Enni-Kaisa
Palomaki, Tiina
Pasanen, Markku
REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2017, 90 : 328 - 341

← 1 2 3 4 5 →